Q3 2024 Holdings
Filed 2024-11-14 | 119 holdings | $5.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $400.9M | 15,021,721 | 7.3% |
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $340.0M | 2,718,735 | 6.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $299.1M | 337,600 | 5.4% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $274.3M | 3,273,000 | 5.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $213.1M | 433,800 | 3.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $203.3M | 7,959,538 | 3.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $157.6M | 813,000 | 2.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $149.4M | 1,316,000 | 2.7% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $130.0M | 782,000 | 2.4% |
| Stryker Corporation(SYK) | COM | 863667101 | $124.4M | 344,400 | 2.3% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $120.2M | 8,288,510 | 2.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $119.2M | 954,500 | 2.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $110.9M | 204,500 | 2.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $104.7M | 179,000 | 1.9% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $100.5M | 2,252,987 | 1.8% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $99.0M | 3,812,215 | 1.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $93.1M | 2,324,447 | 1.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $87.7M | 1,785,571 | 1.6% |
| Natera Inc(NTRA) | COM | 632307104 | $87.3M | 687,500 | 1.6% |
| Amgen Inc(AMGN) | COM | 031162100 | $81.3M | 252,300 | 1.5% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $78.3M | 5,779,071 | 1.4% |
| Integer Hldgs Corp(ITGR) | COM | 45826H109 | $74.8M | 575,000 | 1.4% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $71.1M | 3,027,328 | 1.3% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $70.2M | 151,000 | 1.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $68.8M | 250,300 | 1.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $63.1M | 7,562,971 | 1.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $59.2M | 1,018,734 | 1.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $57.2M | 1,258,566 | 1.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $55.2M | 106,200 | 1.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $53.7M | 1,050,055 | 1.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $52.2M | 84,400 | 0.9% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $49.4M | 73,114,592 | 0.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $48.0M | 1,044,805 | 0.9% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $47.5M | 45,200 | 0.9% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $47.1M | 1,665,115 | 0.9% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $46.3M | 679,816 | 0.8% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $46.2M | 3,305,801 | 0.8% |
| Springworks Therapeutics Inc | COM | 85205L107 | $44.6M | 1,390,631 | 0.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $44.2M | 387,000 | 0.8% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $41.1M | 22,362,850 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $40.5M | 766,906 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $37.1M | 1,925,300 | 0.7% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $36.7M | 6,943,654 | 0.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $36.6M | 1,270,400 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $35.9M | 911,420 | 0.7% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $35.7M | 156,000 | 0.6% |
| Icon PLC(ICLR) | SHS | G4705A100 | $35.6M | 123,900 | 0.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $34.8M | 302,220 | 0.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $29.9M | 675,872 | 0.5% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $29.6M | 1,423,470 | 0.5% |